-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Upgrades Dogwood Therapeutics to Buy, Announces $10 Price Target

Benzinga·04/23/2025 10:47:22
Listen to the news
HC Wainwright & Co. analyst Sean Lee upgrades Dogwood Therapeutics (NASDAQ:DWTX) from Neutral to Buy and announces $10 price target.